NorthWest Biotherapeutics Inc (NWBO)

[Galzus Research]

Roctavian. Ah yes, that's the example you want to lead with in your non-argument

An argument that, for whatever reason, implies that DCVax is an unprecedented breakthrough in cell therapy, as opposed to reality. CAR T-cells, engineered T-cell therapy, adoptive cell therapy, all approved in some form or another on the basis of clear efficacy and outcomes improvement. Your implication is that DCVax is unprecedentedly complex, but I think that just speaks to your AI's lack of familiarity with the history of cell therapy.

But yeah, no, you're right. It'd be just great to end up like Roctavian, taking another what, 6 months before approval from here, only for the product to be discontinued a few years later because the cost/benefit did not meet standards?

A shame that Roctavian's study could actually prove that the gene therapy was doing something. What did the pivotal trial for DCVax-L show as far as the therapy actually doing something? This is really not a dog you want to chase.